DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors

NCT02197169 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma or Gliosarcoma

Interventions

DRUG: Single intratumoral injection of DNX-2401
DRUG: Interferon-gamma

Sponsor

DNAtrix, Inc.